Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression.

MLA

Elango, Ramesh, et al. “Long Noncoding RNA Profiling Unveils LINC00960 as Unfavorable Prognostic Biomarker Promoting Triple Negative Breast Cancer Progression.” Cell Death Discovery, vol. 10, no. 1, July 2024, p. 333. EBSCOhost, https://doi.org/10.1038/s41420-024-02091-3.

APA

Elango, R., Radhakrishnan, V., Rashid, S., Al-Sarraf, R., Akhtar, M., Ouararhni, K., & Alajez, N. M. (2024). Long noncoding RNA profiling unveils LINC00960 as unfavorable prognostic biomarker promoting triple negative breast cancer progression. Cell Death Discovery, 10(1), 333. https://doi.org/10.1038/s41420-024-02091-3

Chicago

Elango, Ramesh, Vishnubalaji Radhakrishnan, Sameera Rashid, Reem Al-Sarraf, Mohammed Akhtar, Khalid Ouararhni, and Nehad M Alajez. 2024. “Long Noncoding RNA Profiling Unveils LINC00960 as Unfavorable Prognostic Biomarker Promoting Triple Negative Breast Cancer Progression.” Cell Death Discovery 10 (1): 333. doi:10.1038/s41420-024-02091-3.